Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11897-017-0321-4 http://scihub22266oqcxt.onion/10.1007/s11897-017-0321-4 C5357587!5357587!28205040     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Heart+Fail+Rep 2017 ; 14 (2): 106-16 Nephropedia Template TP {{tp|p=28205040|t=2017. Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives |pdf=|usr=}}{{28205040}} gab.com Text Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives JO: Curr Heart Fail Rep http://www.kidney.de/pget.php?&tw=1&pmid=28205040 #FOAvip Heart failure (HF) is a complex clinical syndrome with diverse risk factors and etiologies, differing underlying pathophysiology, and large phenotypic heterogeneity. Advances in imaging techniques coupled with clinical trials that targeted only in those with impaired left ventricular ejection fraction (LVEF) have largely shaped the current management strategy for HF that focuses predominantly in patients with systolic HF. In contrast, there are no effective treatments for HF with preserved ejection fraction (HFpEF). Instead of this ?one-size-fits-all? approach to treatment, better precision to define HF phenotypic classifications may lead to more efficient and effective HF disease management. Integrating variables ? including clinical variables, HF biomarkers, imaging, genotypes, metabolomics, and proteomics ? can identify different pathophysiologies, lead to more precise phenotypic classification, and warrant investigation in future clinical trials. Twit Text FOAVip Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives ????Curr Heart Fail Rep http://www.kidney.de/pget.php?&tw=1&pmid=28205040 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28205040 #FOAvip English Wikipedia <ref>{{Cite pmid|28205040}}</ref> Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives #MMPMID28205040 Senthong V; Kirsop JL; Tang WW Curr Heart Fail Rep 2017[Apr]; 14 (2): 106-16 PMID28205040show ga Heart failure (HF) is a complex clinical syndrome with diverse risk factors and etiologies, differing underlying pathophysiology, and large phenotypic heterogeneity. Advances in imaging techniques coupled with clinical trials that targeted only in those with impaired left ventricular ejection fraction (LVEF) have largely shaped the current management strategy for HF that focuses predominantly in patients with systolic HF. In contrast, there are no effective treatments for HF with preserved ejection fraction (HFpEF). Instead of this ?one-size-fits-all? approach to treatment, better precision to define HF phenotypic classifications may lead to more efficient and effective HF disease management. Integrating variables ? including clinical variables, HF biomarkers, imaging, genotypes, metabolomics, and proteomics ? can identify different pathophysiologies, lead to more precise phenotypic classification, and warrant investigation in future clinical trials. äClinical Phenotyping of Heart Failure with Biomarkers: Current and Fut(epmc).pdf DeepDyve Pubget Overpricing